Literature DB >> 17697011

Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.

M Yoneda1, S Saito, T Ikeda, K Fujita, H Mawatari, H Kirikoshi, M Inamori, Y Nozaki, T Akiyama, H Takahashi, Y Abe, K Kubota, T Iwasaki, Y Terauchi, S Togo, A Nakajima.   

Abstract

Insulin resistance (IR) is known to be associated with the visceral adipose tissue area. Elucidation of the relationship between hepatitis C virus (HCV) and IR is of great clinical relevance, because IR promotes liver fibrosis. In this study, we tested the hypothesis that HCV infection by itself may promote IR. We prospectively evaluated 47 patients with chronic HCV infection who underwent liver biopsy. Patients with obesity, type 2 diabetes mellitus (DM), or a history of alcohol consumption were excluded. IR was estimated by calculation of the modified homeostasis model of insulin resistance (HOMA-IR) index. Abdominal fat distribution was determined by computed tomography. Fasting blood glucose levels were within normal range in all the patients. The results of univariate analysis revealed a significant correlation between the quantity of HCV-RNA and the HOMA-IR (r = 0.368, P = 0.0291). While a significant correlation between the visceral adipose tissue area and the HOMA-IR was also observed in the 97 control, nondiabetic, non-HCV-infected patients (r = 0.398, P < 0.0001), no such significant correlation between the visceral adipose tissue area and the HOMA-IR (r = 0.124, P = 0.496) was observed in the patients with HCV infection. Multiple regression analysis with adjustment for age, gender and visceral adipose tissue area revealed a significant correlation between the HCV-RNA and the HOMA-IR (P = 0.0446). HCV is directly associated with IR in a dose-dependent manner, independent of the visceral adipose tissue area. This is the first report to demonstrate the direct involvement of HCV and IR in patients with chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697011     DOI: 10.1111/j.1365-2893.2006.00836.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  15 in total

1.  Is there a direct role of hepatitis C virus in portosystemic encephalopathy?

Authors:  Giovanni Tarantino
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

2.  Relationship of hepatitis C virus infection with diabetes in the U.S. population.

Authors:  Constance E Ruhl; Andy Menke; Catherine C Cowie; James E Everhart
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

3.  Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma.

Authors:  Yin-Hsun Feng; Cheng-Yao Lin; Wen-Tsung Huang; Chia-Ling Wu; Jui-Lung Fang; Chao-Jung Tsao
Journal:  Med Oncol       Date:  2010-08-24       Impact factor: 3.064

4.  Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients.

Authors:  Ching-Sheng Hsu; Shih-Jer Hsu; Hung-Chia Chen; Chen-Hua Liu; Jenher Jeng; Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2012-07-08       Impact factor: 6.047

5.  Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.

Authors:  Amedeo Lonardo; Stefano Ballestri; Luigi E Adinolfi; Enrico Violi; Lucia Carulli; Silvia Lombardini; Federica Scaglioni; Matteo Ricchi; Giuseppe Ruggiero; Paola Loria
Journal:  Can J Gastroenterol       Date:  2009-04       Impact factor: 3.522

6.  Hepatitis C comorbidities affecting the course and response to therapy.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

Review 7.  Steatosis and insulin resistance in hepatitis C: a way out for the virus?

Authors:  José A Del Campo; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

Review 8.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

Review 9.  Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.

Authors:  Suhag Patel; Raxitkumar Jinjuvadia; Ravi Patel; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2016-01       Impact factor: 3.062

Review 10.  Hepatic steatosis: a benign disease or a silent killer.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.